Elsiglutide is a pharmaceutical peptide used in the biomedical industry to manage type 2 diabetes and obesity. It acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, helping to regulate blood sugar levels and promote weight loss. Elsiglutide’s mechanism of action includes increasing insulin release, reducing glucagon secretion, and slowing gastric emptying, resulting in improved glycemic control and decreased appetite.
CAT# | R2022 |
CAS | 914009-84-0 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
The sodium channel subtypes NaV1.2 and NaV1.6 are the two major forms of excitatory pyramidal neurons in the cer ...
Basic Fibroblast Growth Factor, Human, called basic fibroblast growth factor (bFGF/FGF-b/FGF-2), is a single cha ...
Signal peptides stimulate matrix protein production in general and collagen synthesis in specific. They may be accomplished b ...
What are collagen peptides? Collagen peptides are repair collagen, and the protein slowly decreases with age. It can be see ...
Somatostatin is the main hemostatic drug in the clinic, and its derivative octreotide has been confirmed by many ...